glycyrrhizic acid has been researched along with antimony sodium gluconate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bhattacharjee, A; Choudhuri, SK; Majumdar, S; Majumdar, SB; Majumder, S; Roy, S | 1 |
Ghosh, R; Ghosh, S; Juin, SK; Majumdar, S; Majumdar, SB; Roy, N | 1 |
2 other study(ies) available for glycyrrhizic acid and antimony sodium gluconate
Article | Year |
---|---|
Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Biological Transport, Active; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Glycyrrhizic Acid; Leishmania; Leishmaniasis, Visceral; Liver; Mice, Inbred BALB C; Parasite Load; Spleen; Treatment Outcome | 2015 |
Immunomodulator mediated changes in plasma membrane calcium ATPase in controlling visceral leishmaniasis.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Calcium; Calcium-Transporting ATPases; Cell Line; Cell Membrane; Ceramides; Culture Media, Serum-Free; Densitometry; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glycyrrhizic Acid; Imipramine; Immunoblotting; Immunologic Factors; Leishmania donovani; Leishmaniasis, Visceral; Lipopolysaccharides; Macrophages; Mice; Reverse Transcriptase Polymerase Chain Reaction; Reverse Transcription; RNA, Protozoan; RNA, Small Interfering; Transfection | 2020 |